On 6 August 2019, the competent registration court enrolled the Company into the company register of the National Court Register, and as a result, on the basis of Art. 552 of the Commercial Companies Code, the company previously known as „F1 Pharma Spółka z ograniczoną odpowiedzialnością” was transformed into a company under the name of „F1 Pharma Spółka Akcyjna”. This change in the legal status of our company does not in any way affect the continuation of business activities performed by the transformed Company.
New Company Data:
Name: F1 Pharma Spółka Akcyjna;
Address: ul. Profesora Michała Bobrzyńskiego 14, 30 – 348 Kraków;
Registration Court: District Court for Kraków - Śródmieście in Kraków, XI Commercial Department of the National Court Register.
The next F1 Pharma S.A. General Shareholders' Meeting will be held on 28th September 2022 at 11.00.
As a result of the introduction of the Act of 30 August 2019 in the amendment of the Act on Commercial Companies Code and other specific acts (Journal of Laws of 2019, item 1798), obligatory dematerialization of shares of all joint stock companies and limited joint stock partnerships has been introduced.
As a result, shares will not be allowed to have document form and will have to be registered in the registry of shareholders kept by a brokerage house with appropriate authorization for the holding of share accounts, or by a trust bank, or in a deposit held by the Central Securities Depository of Poland. As of 1 January 2021, all shares issued by companies in the form of documents will expire under the letter of the law and as company shareholders will be considered those listed in the current registry.
Further information on the dematerialization of shares will be provided when available.